CTNM
Contineum Therapeutics Inc.
Company Overview
| Mkt Cap | $309.30M | Price | $11.01 |
| Volume | 82.43K | Change | +4.46% |
| P/E Ratio | -7.3 | Open | $10.63 |
| Revenue | -- | Prev Close | $10.54 |
| Net Income | $-42.3M | 52W Range | $3.35 - $20.24 |
| Div Yield | N/A | Target | $22.33 |
| Overall | 46 | Value | 60 |
| Quality | 39 | Technical | 40 |
No chart data available
Stock Overview
Updated DailyContineum Therapeutics Inc. (CTNM) is a leading diversified company in the business industry, currently trading at $11.01 with a market capitalization of $309.30 million. The stock is trading in the middle of its 52-week range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 39.
Today's trading session shows CTNM with a volume of 82K shares. The stock opened up 0.85% from yesterday's close of $10.54. Current analyst estimates project earnings of $-2.39 per share for this year, with next year targeting $-2.47.
CTNM demonstrates weak technical indicators based on technical analysis. The company trades on the NGS exchange.
Key investment considerations for CTNM include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 102.8%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 10:57 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTNM | $11.01 | +4.5% | 82.43K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Contineum Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW